-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… CT examination.
Discussion
Chemoradiation has been the … candidate drug for treating lung cancer. Importantly, epirubicin … arterial chemoembolization in lung cancer patients with hemoptysis. … pathologic assessment of lung cancer resection specimens after …
-
IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
05 Dec 2024 12:23 GMT
… Notes
Small cell lung cancer
Lung cancer is the leading … for people with lung cancer, including and … lung-cancer-101/types-of-lung-cancer.
American Cancer Society. Small cell lung cancer … chemoradiation for patients with limited stage small cell lung cancer …
-
FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer
05 Dec 2024 01:10 GMT
… with limited-stage small cell lung cancer whose disease has not progressed … -durvalumab-limited-stage-small-cell-lung-cancer
Study of durvalumab + tremelimumab, … -cell lung cancer in patients who have not progressed following concurrent chemoradiation therapy …
-
FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations
03 Dec 2024 11:55 GMT
… non-small cell lung cancer (NSCLC) with … and Taiwan).
About lung cancer
Lung cancer is the leading cause … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … resection or definitive chemoradiation, or
metastatic.
KEYTRUDA …
-
Ex-CEO of YouTube Shares Last Message About Lung Cancer
27 Nov 2024 19:54 GMT
… -small-cell lung cancer is the most common type of lung cancer, accounting for … about 85% of diagnosed lung cancer cases each … Lung Cancer Diagnosis and Care” and “Timing Matters When Adding Immunotherapy to Chemoradiation …
-
Lung Cancer Awareness Month: Potential new standard in NSCLC, immunotherapy timing matters
16 Nov 2024 11:54 GMT
… to identify more effective treatments.
Lung Cancer Awareness Month, observed every …
5. Concurrent administration of chemoradiation and immunotherapy did not improve … . Neoadjuvant atezolizumab prior to chemoradiation therapy exhibited promising activity for …
-
From Diagnosis to Delivery: How Multidisciplinary Teams Tackle Stage 3A Lung Cancer
31 Oct 2024 14:31 GMT
… 3 non–small cell lung cancer to receive durvalumab … , molecular pathologist and lung cancer clinical investigator at the … EGFR mutations and their lung cancer responded to [EGFR … chemoradiation in patients with stage iii unresectable non-small cell lung cancer …
-
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
28 Oct 2024 10:49 GMT
… lung cancer have significantly improved in recent years, lung cancer … -009.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … resection or definitive chemoradiation either:
in …
-
Osimertinib Approaches EU Approval in Locally Advanced EGFR+ NSCLC After Chemoradiation
21 Nov 2024 00:07 GMT
… or following platinum-based chemoradiation therapy.1
The … with unresectable, EGFR-mutated lung cancer,” Manuel Cobo, MD, … with unresectable EGFR-mutated lung cancer. News release. AstraZeneca. … , stage III EGFR-mutated lung cancer. News release. AstraZeneca. …
-
Timing of immunotherapy influences benefit in limited-stage small cell lung cancer
17 Oct 2024 10:08 GMT
… limited-stage small cell lung cancer, according to a study … that, in small cell lung cancer, we should not give … : Limited-stage small cell lung cancer is difficult to treat. … small cell lung cancer when immunotherapy is added to chemoradiation. This has …